Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine

Justin A Yax; Eileen C Farnon; N Cary Engleberg

doi:10.1111/j.1708-8305.2009.00336.x

Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine

J Travel Med. 2009 Sep-Oct;16(5):365-7. doi: 10.1111/j.1708-8305.2009.00336.x.

Authors

Justin A Yax¹, Eileen C Farnon, N Cary Engleberg

Affiliation

¹ Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

PMID: 19796110
DOI: 10.1111/j.1708-8305.2009.00336.x

Abstract

Vaccination against yellow fever is effective, but available live virus vaccines are not recommended for use in immunocompromised or elderly patients. We report the successful and uneventful immunization of a 62-year-old man with a history of allogeneic bone marrow transplant and discuss evidence for this recommendation.

Publication types

Case Reports

MeSH terms

Bone Marrow Transplantation*
Contraindications
Ecuador
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Male
Middle Aged
Transplantation, Homologous
Yellow Fever / prevention & control
Yellow Fever Vaccine / administration & dosage*

Substances

Yellow Fever Vaccine